Mepidont

Mepivacaine hydrochloride, the active ingredient in Mepidont, is a local anesthetic (amide type) presented as a dental injectable solution for use in dental procedures. It provides reversible nerve blockade to facilitate painless treatment of teeth and surrounding tissues in adult and pediatric patients.

GNH USA supplies Mepidont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union quality standards and offering reliable global distribution.

Mepidont is used in dental practice to achieve local anesthesia for a range of oral procedures.

Tooth extractions: provides rapid and profound numbness to enable painless removal of teeth. Pulp therapy: allows comfortable access to the dental pulp for treatment of inflammation or infection. Periodontal surgery: creates a pain‑free field for gum and supporting tissue procedures.

Mepidont may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Transient numbness at the injection site - Mild swelling or bruising - Temporary taste alteration - Mild headache

Serious or Rare Side Effects: - Allergic reaction such as rash, itching or swelling - Cardiovascular effects like tachycardia or hypertension - Seizure activity in susceptible individuals

When using Mepidont, clinicians should observe several precautionary measures to ensure patient safety.

Allergy assessment: confirm no known hypersensitivity to amide anesthetics or epinephrine. Cardiovascular status: evaluate blood pressure and heart rate before administration of epinephrine‑containing solution. Dosage limitation: avoid exceeding recommended maximum dose for the patient’s weight and health condition. Drug history: review concurrent use of monoamine oxidase inhibitors or non‑selective beta‑blockers. Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. Store at ambient temperature: keep in original container, protect from light and moisture.

Mepidont can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis due to epinephrine. - Non‑selective beta‑blockers: may potentiate cardiovascular effects of epinephrine. - Tricyclic antidepressants: increase risk of arrhythmias when combined with epinephrine.

Moderate Interactions (Monitor Closely): - Selective beta‑blockers: may require blood pressure monitoring. - Antihypertensive agents: possible additive hypotensive effect after anesthetic wears off. - Other local anesthetics: cumulative toxicity risk if multiple agents are used.